Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) [Phase 2]

View source ↗

Summary

This Phase 2 study evaluating THR-317 for diabetic macular edema has completed enrollment and data collection to assess safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• THR-317

Snippet

Sponsor: ThromboGenics | Conditions: Diabetic Retinopathy, Macular Edema | Phase 2 | Status: COMPLETED